Severe Malaria in African Children - The Need for Continuing Investment.
作者信息
Maitland Kathryn
机构信息
From the Wellcome Centre for Clinical Tropical Medicine, Imperial College, London.
出版信息
N Engl J Med. 2016 Dec 22;375(25):2416-2417. doi: 10.1056/NEJMp1613528.
Abstract
摘要
相似文献
1
Severe Malaria in African Children - The Need for Continuing Investment.
N Engl J Med. 2016 Dec 22;375(25):2416-2417. doi: 10.1056/NEJMp1613528.
2
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
Lancet. 2010 Nov 13;376(9753):1647-57. doi: 10.1016/S0140-6736(10)61924-1. Epub 2010 Nov 7.
3
Management of severe paediatric malaria in resource-limited settings.
BMC Med. 2015 Mar 3;13:42. doi: 10.1186/s12916-014-0263-6.
4
Shifting from quinine to artesunate as first-line treatment of severe malaria in children and adults: saving more lives.
J Infect Public Health. 2014 Sep-Oct;7(5):407-12. doi: 10.1016/j.jiph.2014.04.007. Epub 2014 Jun 2.
5
For severe malaria, artesunate is the answer.
Lancet. 2010 Nov 13;376(9753):1621-2. doi: 10.1016/S0140-6736(10)61928-9. Epub 2010 Nov 7.
6
Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.
Bull World Health Organ. 2011 Jul 1;89(7):504-12. doi: 10.2471/BLT.11.085878. Epub 2011 Apr 28.
7
Compliance With Referral Advice After Treatment With Prereferral Rectal Artesunate: A Study in 3 Sub-Saharan African Countries.
Clin Infect Dis. 2016 Dec 15;63(suppl 5):S283-S289. doi: 10.1093/cid/ciw627.
8
Artesunate versus quinine for treating severe malaria.
Cochrane Database Syst Rev. 2007 Oct 17(4):CD005967. doi: 10.1002/14651858.CD005967.pub2.
9
Parenteral artesunate access programme aims at reducing malaria fatality rates in South Africa.
S Afr Med J. 2011 Apr;101(4):240-1. doi: 10.7196/samj.4761.
10
Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas.
Eur J Clin Microbiol Infect Dis. 2008 Jul;27(7):627-9. doi: 10.1007/s10096-008-0464-z. Epub 2008 Feb 12.
引用本文的文献
1
Combating Malaria: Targeting the Ubiquitin-Proteasome System to Conquer Drug Resistance.
Trop Med Infect Dis. 2025 Apr 3;10(4):94. doi: 10.3390/tropicalmed10040094.
2
Association Between Plasmodium Infection and Blood Count Values: Implications for Malaria Diagnosis in Resource-Limited Settings.
Acta Parasitol. 2025 Jan 28;70(1):47. doi: 10.1007/s11686-024-00972-2.
3
Alteration of ceruloplasmin in patients with malaria: a systematic review and meta-analysis of observational studies.
Malar J. 2024 Nov 21;23(1):353. doi: 10.1186/s12936-024-05156-x.
4
Quality of care and post-discharge morbidity among children diagnosed with severe malaria in rural Uganda: A prospective cohort study.
PLOS Glob Public Health. 2024 Oct 7;4(10):e0003794. doi: 10.1371/journal.pgph.0003794. eCollection 2024.
5
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).
Wellcome Open Res. 2024 Aug 12;8:484. doi: 10.12688/wellcomeopenres.20111.2. eCollection 2023.
6
Examining the disparities of anti-malarial drug consumption among children under the age of five: a study of 5 malaria-endemic countries.
Malar J. 2023 Dec 5;22(1):370. doi: 10.1186/s12936-023-04805-x.
7
Is there a role for bradykinin in cerebral malaria pathogenesis?
Front Cell Infect Microbiol. 2023 Aug 10;13:1184896. doi: 10.3389/fcimb.2023.1184896. eCollection 2023.
8
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.
Trials. 2023 Apr 5;24(1):257. doi: 10.1186/s13063-023-07274-4.
9
Prevalence and associated risk factors of malaria among febrile under-five children visiting health facilities in Ziquala district, Northeast Ethiopia: A multicenter cross-sectional study.
PLoS One. 2022 Oct 27;17(10):e0276899. doi: 10.1371/journal.pone.0276899. eCollection 2022.
10
Model of severe malaria in young mice suggests unique response of CD4 T cells.
Parasite Immunol. 2022 Dec;44(12):e12952. doi: 10.1111/pim.12952. Epub 2022 Oct 4.
本文引用的文献
1
The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity.
Lancet. 2014 May 17;383(9930):1739-47. doi: 10.1016/S0140-6736(13)62566-0. Epub 2014 Feb 20.
2
Mortality after fluid bolus in African children with severe infection.
N Engl J Med. 2011 Jun 30;364(26):2483-95. doi: 10.1056/NEJMoa1101549. Epub 2011 May 26.
3
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
Lancet. 2010 Nov 13;376(9753):1647-57. doi: 10.1016/S0140-6736(10)61924-1. Epub 2010 Nov 7.
Zotero 插件